"More is not necessarily better" when it comes to vitamin D supplements for women with adequate serum levels, new research suggests. In a study of healthy 55- to 70-year-old women who took…
Gut microbiome plays a vital role in patients with Huntington's disease. Some of the gut measures are associated with disease symptoms, such as impaired movements and thinking. The findings, published…
The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir is indicated for use in…
COVID-19 concerns should not stop patients from using inhaled corticosteroids, a new commentary article suggests. While patients with pulmonary diseases are at increased risk of developing COVID-19, those treatments may…
A new combination of biomarkers from baseline tumor tissues was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors in patients with advanced metastatic bladder…
The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children at least 4 weeks old and…
